Подписаться
Jose Mauricio Mota
Jose Mauricio Mota
Instituto do Câncer do Estado de São Paulo
Подтвержден адрес электронной почты в домене hc.fm.usp.br
Название
Процитировано
Процитировано
Год
Wnt/beta-catenin pathway: modulating anticancer immune response
SG Pai, BA Carneiro, JM Mota, R Costa, CA Leite, R Barroso-Sousa, ...
Journal of hematology & oncology 10, 1-12, 2017
5612017
Neutrophil extracellular traps induce organ damage during experimental and clinical sepsis
PG Czaikoski, JMSC Mota, DC Nascimento, F Sônego, FVS Castanheira, ...
PloS one 11 (2), e0148142, 2016
3572016
Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1 profile in a TLR4-dependent manner
CW Wanderley, DF Colon, JPM Luiz, FF Oliveira, PR Viacava, CA Leite, ...
Cancer research 78 (20), 5891-5900, 2018
3372018
The rising incidence of younger patients with colorectal cancer: questions about screening, biology, and treatment
LC Connell, JM Mota, MI Braghiroli, PM Hoff
Current treatment options in oncology 18, 1-20, 2017
2192017
Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution
PMG Soares, JMSC Mota, AS Gomes, RB Oliveira, AMS Assreuy, ...
Cancer chemotherapy and pharmacology 63, 91-98, 2008
1642008
Tumor microenvironment-derived NRG1 promotes antiandrogen resistance in prostate cancer
Z Zhang, WR Karthaus, YS Lee, VR Gao, C Wu, JW Russo, M Liu, ...
Cancer Cell 38 (2), 279-296. e9, 2020
1592020
Irinotecan-and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives
RA Ribeiro, CWS Wanderley, DVT Wong, JMSC Mota, CAVG Leite, ...
Cancer chemotherapy and pharmacology 78, 881-893, 2016
1522016
Platinum-based chemotherapy in metastatic prostate cancer with DNA repair gene alterations
JM Mota, E Barnett, JT Nauseef, B Nguyen, KH Stopsack, A Wibmer, ...
JCO precision oncology 4, 355-366, 2020
1072020
Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4
PMG Soares, JMSC Mota, EP Souza, PFC Justino, AX Franco, FQ Cunha, ...
Cytokine 61 (1), 46-49, 2013
952013
A networked learning framework for effective MOOC design: the ECO project approach
F Brouns, J Mota, L Morgado, D Jansen, S Fano, A Silva, A Teixeira
8th EDEN Research Workshop. Challenges for research into open & distance …, 2014
852014
Pan-cancer analysis of CDK12 alterations identifies a subset of prostate cancers with distinct genomic and clinical characteristics
B Nguyen, JM Mota, S Nandakumar, KH Stopsack, E Weg, D Rathkopf, ...
European urology 78 (5), 671-679, 2020
832020
Complications from carcinoid syndrome: review of the current evidence
JM Mota, LG Sousa, RP Riechelmann
Ecancermedicalscience 10, 2016
822016
A proposal for the methodological design of collaborative language mooc
A Teixeira, J Mota
Language MOOCs: Providing learning, transcending boundaries, 33-47, 2014
812014
A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer
JM Mota, KA Collier, RLB Costa, T Taxter, A Kalyan, CA Leite, YK Chae, ...
Oncotarget 8 (51), 89284, 2017
672017
Amifostine and glutathione prevent ifosfamide-and acrolein-induced hemorrhagic cystitis
C Batista, J Mota, MLP Souza, BTA Leitão, M Souza, GAC Brito, ...
Cancer chemotherapy and pharmacology 59, 71-77, 2007
632007
Post-sepsis state induces tumor-associated macrophage accumulation through CXCR4/CXCL12 and favors tumor progression in mice
JM Mota, CA Leite, LE Souza, PH Melo, DC Nascimento, ...
Cancer Immunology Research 4 (4), 312-322, 2016
542016
Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice
PMG Soares, RCP Lima-Junior, JMSC Mota, PFC Justino, GAC Brito, ...
Cancer chemotherapy and pharmacology 68, 713-720, 2011
542011
Chemotherapy-induced hemorrhagic cystitis: pathogenesis, pharmacological approaches and new insights
RA Ribeiro, RCP Lima-Junior, C Leite, J Mota, FY Macedo, MV Lima, ...
J Exp Integr Med 2 (2), 95-112, 2012
402012
Gastric damage induced by different doses of indomethacin in rats is variably affected by inhibiting iNOS or leukocyte infiltration
M Souza, J Mota, RB Oliveira, FQ Cunha
Inflammation Research 57, 28-33, 2008
402008
Acquired lipodystrophy associated with nivolumab in a patient with advanced renal cell carcinoma
CK Falcao, MCS Cabral, JM Mota, ST Arbache, AD Costa-Riquetto, ...
The Journal of Clinical Endocrinology & Metabolism 104 (8), 3245-3248, 2019
372019
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20